RxDoctor Payments Data

Anne Cameron, MD

Urogynecology and Reconstructive Pelvic Surgery · Brighton, MINPI 1629267042

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (37.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Medtronic at 32.4% of the total.

$6,805in general payments, 2019–2025

Across 55 payments — averaging $123.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Axonics, Inc.$2K
  • Dentsply IH Inc.$1K
  • Boston Scientific$624
  • AbbVie$189
  • Coloplast$113
$81,281in research payments, 2019–2025

Across 24 payments — averaging $3386.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$81K

What the payments were for

  • Consulting fees$2,00029%
  • Speaking & faculty fees$1,00015%
  • Travel & lodging$1,20118%
  • Food & beverage$2,58238%
  • Education$220%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)30$2,207
Axonics, Inc.3$2,206
Dentsply IH Inc.7$1,466
Boston Scientific8$624
AbbVie5$189
Coloplast2$113

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,805 in reported general payments places this provider in the 80th percentile of 33 urogynecology and reconstructive pelvic surgery providers in Michigan.

See all urogynecology and reconstructive pelvic surgery providers in Michigan

Medicare billing

Part B allowed, 2024
$63,991
Medicare patients
270
Services billed
607

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron227$207,172
GemtesaVibegron79$75,925
Mirabegron ErMirabegron51$33,617
Trospium Chloride ErTrospium Chloride49$11,180
PremarinEstrogens, Conjugated24$10,049
Gentamicin Sulfate182$9,359
Methenamine Hippurate60$7,762
Estradiol53$6,718
Trimethoprim75$5,979
Desmopressin Acetate29$2,518
Tolterodine Tartrate ErTolterodine Tartrate21$1,832
Tamsulosin Hcl90$1,602
Trospium Chloride11$1,399
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst28$834
Solifenacin Succinate12$731

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in Brighton

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →